Inventor
HU LONGQIN
US11 patents
⚠️ This page may combine multiple inventors who share the name “HU LONGQIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV RUTGERS
9 patentsUS10836737B2Nov 17, 2020
Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
UNIV RUTGERS3 citations68
US10106502B2Oct 23, 2018
Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulators
UNIV RUTGERS2 citations68
US11420949B2Aug 23, 2022
Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
UNIV RUTGERS0 citations59
US12391661B2Aug 19, 2025
Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
UNIV RUTGERS0 citations57
US9428453B2Aug 30, 2016
Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
UNIV RUTGERS2 citations57
US11628221B2Apr 18, 2023
Peptide linker and combination for prodrugs activated by prostate-specific antigen
UNIV RUTGERS0 citations53
US11129901B2Sep 28, 2021
Peptide-linked ester prodrugs activated by prostate-specific antigen
UNIV RUTGERS0 citations53
US12486241B2Dec 2, 2025
Cystine diamide analogs for cystinuria
UNIV RUTGERS0 citations40
US12122742B2Oct 22, 2024
Small molecule direct inhibitors of KEAP1-NRF2 protein-protein interaction
UNIV RUTGERS0 citations40